Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
He urged the companies to speed up the production of more doses in order to cover more population by December end
Representatives from seven vaccine makers -- Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech -- will be participating in the meeting.